Translational Biomarkers in Alzheimer Disease Research, Part 5
This last section of our 5-part news report on a recent workshop on translational biomarkers summarizes contributions by...
ALL NEWS
471 RESULTS
Sort By:
- Most Recent
- Most Commented
Translational Biomarkers in Alzheimer Disease Research, Part 4
This is part 4 of a 5-part series. See also <a href="/news/conference-coverage/translational-biomarkers-alzheimer-disease-research-part-1">part 1</a>, <a href="/news/conference-coverage/translational-biomarkers-alzheimer-disease-research-part-2">part 2</a>, and <a href="/news/conference-coverage/translational-biomarkers-alzheimer-disease-research-part-3">part 3</a>...
Translational Biomarkers in Alzheimer Disease Research, Part 3
This is part 3 of a 5-part series. See also <a href="/news/conference-coverage/translational-biomarkers-alzheimer-disease-research-part-1">part 1</a> and <a href="/news/conference-coverage/translational-biomarkers-alzheimer-disease-research-part-2">part 2</a>...
Translational Biomarkers in Alzheimer Disease Research, Part 2
This is Part 2 of a 5-part series. See <a href="/news/conference-coverage/translational-biomarkers-alzheimer-disease-research-part-1">part 1</a> for introduction...
Translational Biomarkers in Alzheimer Disease Research, Part 1
This is part 1 of a 5-part series...
SfN: Early Steps toward Parkinson Disease Blood Test
Biomarkers are the buzz of the field these days, and the hum was heard inside the beltway at the 35th Annual Conference of the Society for Neuroscience...
Making a Vaccine Work: Profiles, Protein Synthesis, and Synapses
After the Elan-Wyeth phase 2a trial on the AN1792 Aβ vaccine had to be halted because some patients developed meningeal encephalitis, scientists have...
Looking outside the Brain for Early Signs of AD
The use of gene expression profiling to characterize Alzheimer disease pathology has, unsurprisingly, focused on...
Sorrento: They’ve Just Got to Have It—Where’s That Biomarker? Part 1
This is part 1 of a biomarker update from Sorrento.
Sorrento: They’ve Just Got to Have It—Where’s That Biomarker? Part 2
This is part 2 of the biomarker update from Sorrento.
"Bio-Barcode" Amplifies Aβ Oligomer Signal, Proffers Candidate Diagnostic Test
By amplifying small quantities of Aβ oligomer in cerebrospinal fluid, a methodology referred to as the "bio-barcode" could serve as a diagnostic or monitoring test for AD...
GSK-3—A Peripheral Marker for AD?
Finding an easily measurable antecedent marker for Alzheimer disease would be a major development. Might glycogen synthase kinase fit the bill?...
CSF Proteomics Test for ALS?
Surveying the protein profile of a tissue or body fluid by traditional methods has not proven a very efficient way to detect changes in protein levels in neurodegenerative diseases...
New Marker for AD on the Horizon?
The chemokine receptor CCR1 might be an early and specific marker of Alzheimer's disease, researchers suggest in the November issue of Annals of Neurology, now available online...
Biomarker Bonus: Phospho-Tau/Aβ Ratio Increase Sensitivity
The ratio of phosphorylated tau (p-tau) to β-amyloid (Aβ) in the cerebrospinal fluid improves the ability to distinguish clinically defined Alzheimer's patients from normal subjects, according to a study...